Study: Dense breast notifications are informative but hard to read and understand
Contents
At a glance | Questions for your doctor |
Findings | In-depth |
Clinical trials | Limitations |
Guidelines | Resources |
STUDY AT A GLANCE
What is this study about?
In almost half of the states in the U.S., some or all women receive a dense breast notification (DBN) with their . But do women understand what these notifications are trying to say?
Why is this study important?
Information that is difficult to read or understand may fail its purpose to inform women about dense breasts, whether they may have them, and important alternatives to .
Study findings:
- The majority of DBNs explain that breasts with dense tissue can hide cancer on , and that they are linked to an increased risk of breast cancer. The notifications also identify other options for screening dense breasts. But while these DBNs include all of this information, researchers found that the documents are hard to understand, and the majority of them were written at a reading level that is too high.
What does this mean for me?
This research indicates that dense breast notifications, while informative, are difficult to read and understand. Women who have any questions about their DBN or screening results should never hesitate to contact their health care provider for clarification, because it is important that all patients understand information that is presented to them.
Posted 6/7/16
Share your thoughts on this XRAYS article by taking this brief survey.
References
Kressin NR, Gunn CM, Battaglia TA. “Content, Readability, and Understandability of Dense Breast Notifications by State.” JAMA. April 26, 2016, Volume 315, Number 16, 1786-788.
Disclosure
FORCE receives funding from industry sponsors, including companies that manufacture cancer drugs, tests and devices. All XRAYS articles are written independently of any sponsor and are reviewed by members of our Scientific Advisory Board prior to publication to assure scientific integrity.
This article is relevant for:
Women with dense breast tissue on mammograms
This article is also relevant for:
previvors
people with a genetic mutation linked to cancer risk
healthy people with average cancer risk
Be part of XRAY:
IN DEPTH REVIEW OF RESEARCH
Study background:
Dense breasts can hide cancer on , and they are a risk factor for cancer. Because of this, almost half of U.S. states include information on dense breasts with results, because it can help women make informed decisions about what to do next.
Nancy Kressin and her colleagues from the Boston University School of Medicine published a letter in the journal JAMA regarding their efforts to determine whether information included in DBNs is readable and understandable.
Population(s) looked at in the study:
The researchers studied the dense breast notifications from all states that issue them. They assessed content, readability (using two tests that measure the reading grade level of text) and understandability (using the Patient Education Materials Assessment Tool that measures patient understanding).
Study findings:
- 24 of 50 U.S. states require that women’s screening results also include a dense breast notification. The researchers studied the DBNs of 23 of these states.
- 7 of 23 states require that all women receive generic information about breast density. Women with dense breasts get additional information on breast density.
- 16 of 23 states provide information about breast density only to women who have dense breasts.
- All of the 23 states included in the study provide dense breast notifications that mention the potential for dense breasts to hide cancers on .
- 18 of 23 states provide dense breast notifications that include information about the increased risk of breast cancer that is linked to dense breasts.
- 14 of 23 states provide dense breast notifications that include information about supplemental screening for women with dense breasts.
- On average, DBNs reviewed are written at a 10th grade reading level. This is higher than the recommended reading level (7th-8th grade) for patient information.
- All dense breast notifications reviewed have very low understandability scores.
Limitations:
While this study focused on the text included in dense breast notifications, it did not have any data on related outcomes. Did the women from states with dense breast notifications have less anxiety or more cancer detected? So while the researchers know about the readability and understandability of dense breast notifications, they do not know how these factors affect women after they receive their results. Further research is needed to determine whether the current low reading level of dense breast notifications improve a patient’s ability to make decisions about breast cancer screening.
Conclusions:
This study indicates that the reading level of dense breast notifications is too high, making them hard to understand. Another study is needed to see the effect this has on outcomes, but as the study authors wrote, “Efforts should focus on enhancing the understandability of dense breast notifications so that all women are clearly and accurately informed about their density status, its effect on their breast cancer risk and the harms and benefits of supplemental screening.” If dense breast notifications are hard to read and understand, women may glance over and disregard the information, even though it is information that they should know about themselves. If a patient is having difficulty understanding her dense breast notification or any screening result, she should not hesitate to contact a health care provider for further clarification.
It is important to remember that dense breasts are just one indication for increased breast cancer screening. Women with a family history of cancer, a mutation in BRCA1/2 or other gene that increases breast cancer risk, or a personal history of breast cancer should discuss appropriate breast cancer screening with their health care providers.
Posted 6/7/16
Share your thoughts on this XRAYS article by taking this brief survey.
Laws and guidelines address screening of women with dense breasts. Laws regarding breast density notification vary by state. The National Comprehensive Cancer Network (NCCN) has guidelines on breast screening. The panel notes that dense breasts are associated with an increased risk for breast cancer, and they recommend the following:
- Women with dense breasts identified by a should be counseled on the risks and benefits of additional breast screening.
- Digital benefit young women and women with dense breasts.
- (3D ) can increase cancer detection and lower the chances of additional call backs.
- may improve the detection of cancers in women with dense breasts but it can also increase the number of callbacks and biopsies of benign (noncancerous) tissue.
Updated: 02/06/2022
- What does having dense breasts mean for me?
- How can I lower my breast cancer risk?
- I have a dense breast notification and carry a mutation in a gene that increases cancer risk. How does this affect my screening options?
- What other screening methods can I use?
- I live in a state that does not provide a dense breast notification with my screening result. How do I know if I have dense breasts?
- Who do I contact if I do not understand what my Dense Breast Notification says?
The following are breast cancer screening or prevention studies enrolling people at high risk for breast cancer.
- NCT04711109: Denosumab for Preventing Breast Cancer in Women with a Inherited Mutation (BRCA-P). This study will test the effectiveness of a drug (denosumab) in preventing the development of breast cancer in women with an inherited mutation.
- NCT04067726: Denosumab and Mammographic Density in Premenopausal Women With Dense Breasts (TRIDENT). This study is looking at the drug denosumab to learn if it can reduce breast density in high-risk premenopausal women who have dense breasts.
- The Risk Factor Analysis of Hereditary Breast and Ovarian Cancer In Women with , or Mutations. This study seeks to improve researchers’ understanding of how hormonal, reproductive and lifestyle factors may be associated with cancer in high-risk people.
- NCT02620852: Women Informed to Screen Depending on Measures of Risk (WISDOM) study. The goal of this study is to determine if breast cancer screening can be improved by personalizing each woman’s schedule, compared to the current one-size-fits-all annual approach.
-
NCT04674306: Therapy With an Alpha-lactalbumin Vaccine in . This study is testing a new vaccine to lower the risk of breast cancer in high-risk women with an in , or .
Additional risk-management clinical trials for people at high risk for breast cancer may be found here.
Updated: 01/24/2024
Who covered this study?
The New York Times
Notifications about dense breasts can be hard to interpret This article rates 4.5 out of 5 stars
Boston University
Also published in:
The same article was also covered by Medical Xpress
Study finds readability of dense breast notifications poor This article rates 4.0 out of 5 stars
Healio
Studies address appropriate ways to notify, screen women with dense breasts This article rates 3.5 out of 5 stars